Aurélien Lathuilière

1.1k total citations
31 papers, 435 citations indexed

About

Aurélien Lathuilière is a scholar working on Physiology, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Aurélien Lathuilière has authored 31 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Physiology, 14 papers in Molecular Biology and 8 papers in Psychiatry and Mental health. Recurrent topics in Aurélien Lathuilière's work include Alzheimer's disease research and treatments (15 papers), Dementia and Cognitive Impairment Research (8 papers) and Virus-based gene therapy research (4 papers). Aurélien Lathuilière is often cited by papers focused on Alzheimer's disease research and treatments (15 papers), Dementia and Cognitive Impairment Research (8 papers) and Virus-based gene therapy research (4 papers). Aurélien Lathuilière collaborates with scholars based in Switzerland, United States and Sweden. Aurélien Lathuilière's co-authors include Bernard L. Schneider, Patrick Aebischer, Bradley T. Hyman, Matthias P. Lütolf, Nicolas Mach, Steffen Cosson, Simon Dujardin, Mary Migliorini, Dudley K. Strickland and Selen C. Muratoglu and has published in prestigious journals such as Journal of Biological Chemistry, Biomaterials and Brain.

In The Last Decade

Aurélien Lathuilière

29 papers receiving 432 citations

Peers

Countries citing papers authored by Aurélien Lathuilière

Since Specialization

Citations

This map shows the geographic impact of Aurélien Lathuilière's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurélien Lathuilière with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurélien Lathuilière more than expected).

Fields of papers citing papers by Aurélien Lathuilière

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurélien Lathuilière. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurélien Lathuilière. The network helps show where Aurélien Lathuilière may publish in the future.

Co-authorship network of co-authors of Aurélien Lathuilière

This figure shows the co-authorship network connecting the top 25 collaborators of Aurélien Lathuilière. A scholar is included among the top collaborators of Aurélien Lathuilière based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurélien Lathuilière. Aurélien Lathuilière is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fecal Microbiota Transplantation (FMT) From a Human at Low Risk for Alzheimer's Disease Improves Short‐Term Recognition Memory and Increases Neuroinflammation in a 3xTg AD Mouse Model 2025 ·Genes Brain & Behavior ·Claire Chevalier, Benjamin B. Tournier, Moira Marizzoni, Rahel Park, (unknown), Kelly Ceyzériat, (unknown), Aurélien Lathuilière, (unknown), (unknown), Annamaria Cattaneo, P. Millet, Giovanni B. Frisoni	4
2	[18F]flutemetamol uptake in the colon of a memory clinic population and its association with brain amyloidosis and the gut microbiota profile: an exploratory study 2025 ·European Journal of Nuclear Medicine and Molecular Imaging ·(unknown), Elena Gatti, Débora Elisa Peretti, Marco Aiello, Claire Chevalier, Aurélien Lathuilière, Rahel Park, Michela Pievani, Marco Salvatore, Max Scheffler, Annamaria Cattaneo, Giovanni B. Frisoni, Valentina Garibotto, Moira Marizzoni	1
3	TSPO contributes to neuropathology and cognitive deficits in Alzheimer’s disease 2025 ·Journal of Neuroinflammation ·Kelly Ceyzériat, (unknown), Laurene Abjean, (unknown), (unknown), (unknown), (unknown), (unknown), Ryan J. Middleton, Guo Jun Liu, Richard B. Banati, Thomas Zilli, Aurélien Lathuilière, David R. Owen, Pierre Maechler, Valentina Garibotto, Stergios Tsartsalis, P. Millet, Benjamin B. Tournier	0
4	Head-to-head study of diagnostic accuracy of plasma and cerebrospinal fluid p-tau217 versus p-tau181 and p-tau231 in a memory clinic cohort 2024 ·Journal of Neurology ·(unknown), Federica Ribaldi, Aurélien Lathuilière, Nicholas J. Ashton, Shorena Janelidze, Henrik Zetterberg, Max Scheffler, Frédéric Assal, Valentina Garibotto, Kaj Blennow, Oskar Hansson, Giovanni B. Frisoni	36
5	Comparison of plasma and neuroimaging biomarkers to predict cognitive decline in non-demented memory clinic patients 2024 ·Alzheimer s Research & Therapy ·(unknown), Federica Ribaldi, Aurélien Lathuilière, Nicholas J. Ashton, Henrik Zetterberg, Marc Abramowicz, Max Scheffler, Frédéric Assal, Valentina Garibotto, Kaj Blennow, Giovanni B. Frisoni	7
6	SORL1 is a receptor for tau that promotes tau seeding 2024 ·Journal of Biological Chemistry ·(unknown), Aurélien Lathuilière, Enming J. Su, Yuyu Song, Daniel Torrente, Youhwa Jo, (unknown), (unknown), Mary Migliorini, Thomas H. Sisson, Daniel A. Lawrence, Bradley T. Hyman, Dudley K. Strickland	7
7	Superiority of p‐tau217 among plasma biomarkers in diagnostic accuracy in non‐demented persons from the Geneva Memory Center cohort 2024 ·Alzheimer s & Dementia ·(unknown), Federica Ribaldi, Aurélien Lathuilière, Nicholas J. Ashton, Shorena Janelidze, Henrik Zetterberg, Max Scheffler, Frédéric Assal, Valentina Garibotto, Kaj Blennow, Oskar Hansson, Giovanni B. Frisoni	0
8	Plasma biomarkers for Alzheimer’s disease: a field-test in a memory clinic 2023 ·Journal of Neurology Neurosurgery & Psychiatry ·Daniele Altomare, (unknown), Federica Ribaldi, Szymon Tomczyk, Claire Chevalier, Géraldine Poulain, (unknown), (unknown), Moira Marizzoni, (unknown), Aurélien Lathuilière, Max Scheffler, Nicholas J. Ashton, Henrik Zetterberg, Kaj Blennow, Ilse Kern, Miguel A. Frias, Valentina Garibotto, Giovanni B. Frisoni	39
9	Specific detection of tau seeding activity in Alzheimer’s disease using rationally designed biosensor cells 2023 ·Molecular Neurodegeneration ·Aurélien Lathuilière, Youhwa Jo, Romain Perbet, (unknown), Caitlin Commins, Noé Quittot, Zhanyun Fan, Rachel E. Bennett, Bradley T. Hyman	6
10	Association of AD risk factors with plasma GFAP levels in a memory clinic population 2023 ·Alzheimer s & Dementia ·Moira Marizzoni, Claire Chevalier, (unknown), Henrik Zetterberg, Kaj Blennow, Aurélien Lathuilière, Federica Ribaldi, (unknown), Jean‐Louis Blouin, Marc Abramowicz, Michela Pievani, Valentina Garibotto, Giovanni B. Frisoni	2
11	Engineering a versatile and retrievable cell macroencapsulation device for the delivery of therapeutic proteins 2023 ·iScience ·(unknown), (unknown), Emily Charrier, (unknown), Olivier Rohr, (unknown), (unknown), Aurélien Lathuilière, Nicolas Gaudenzio, Adrien Engel, Nicolas Mach	2
12	Plasma SNAP‐25 as a potential Alzheimer’s disease biomarker 2023 ·Alzheimer s & Dementia ·Federica Ribaldi, (unknown), Henrik Zetterberg, Kaj Blennow, (unknown), Aurélien Lathuilière, Valentina Garibotto, Nicholas J. Ashton, Eugeen Vanmechelen, Giovanni B. Frisoni	2
13	Immortalized human myoblast cell lines for the delivery of therapeutic proteins using encapsulated cell technology 2022 ·Molecular Therapy — Methods & Clinical Development ·Aurélien Lathuilière, (unknown), Emily Charrier, (unknown), Olivier Rohr, (unknown), (unknown), (unknown), Davy Guillarme, Adrien Engel, Patrick Salmon, Thomas Laumonier, (unknown), Nicolas Mach	8
14	Regulation of tau internalization, degradation, and seeding by LRP1 reveals multiple pathways for tau catabolism 2021 ·Journal of Biological Chemistry ·(unknown), Aurélien Lathuilière, Mary Migliorini, (unknown), (unknown), Simon Dujardin, Selen C. Muratoglu, Bradley T. Hyman, Dudley K. Strickland	87
15	Motifs in the tau protein that control binding to microtubules and aggregation determine pathological effects 2017 ·Scientific Reports ·Aurélien Lathuilière, Pamela Valdés, Stéphanie Papin, Matthias Cacquevel, Catherine Maclachlan, Graham Knott, Andreas Muhs, Paolo Paganetti, Bernard L. Schneider	36
16	Un implant bioactif pour prévenir la maladie d’Alzheimer 2017 ·médecine/sciences ·Aurélien Lathuilière, Bernard L. Schneider	1
17	A subcutaneous cellular implant for passive immunization against amyloid-β reduces brain amyloid and tau pathologies 2016 ·Brain ·Aurélien Lathuilière, (unknown), Alberto Astolfo, Erhard Kopetzki, Helmut Jacobsen, Marco Stampanoni, Bernd Bohrmann, Bernard L. Schneider, Patrick Aebischer	34
18	Amyloid-β plaque deposition measured using propagation-based X-ray phase contrast CT imaging 2016 ·Journal of Synchrotron Radiation ·Alberto Astolfo, Aurélien Lathuilière, (unknown), Bernard L. Schneider, Marco Stampanoni	20
19	A high-capacity cell macroencapsulation system supporting the long-term survival of genetically engineered allogeneic cells 2013 ·Biomaterials ·Aurélien Lathuilière, Steffen Cosson, Matthias P. Lütolf, Bernard L. Schneider, Patrick Aebischer	53
20	Cell death pathways differ in several mouse models with motoneurone disease: analysis of pure motoneurone populations at a presymptomatic age 2006 ·Journal of Neurochemistry ·Florence E. Perrin, (unknown), Aurélien Lathuilière, Ann C. Kato	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact